283

Compound name
Nilotinib
Alt Name
Tasigna
Compound Image
Nilotinib.png
SMILES
CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
Brutto
C28H22F3N7O
InChI
InChI=1S/C28H22F3N7O/c1-17-5-6-19(10-25(17)37-27-33-9-7-24(36-27)20-4-3-8-32-14-20)26(39)35-22-11-21(28(29,30)31)12-23(13-22)38-15-18(2)34-16-38/h3-16H,1-2H3,(H,35,39)(H,33,36,37)
InChI Key
HHZIURLSWUIHRB-UHFFFAOYSA-N
Approval Jurisdiction
2007 FDA
Approved for clinical use
Chronic Myelogenous Leukemia
CAS
641571-10-0
PubChem CID
644241
Action
Bcr-Ab1
Approved Drug List
1
Commercial Vendor
Novartis